Monopar Therapeutics logo

Monopar Therapeutics Share Price (NASDAQ: MNPR)

$36.03

1.22

(3.5%)

Last updated on

Check the interactive Monopar Therapeutics Stock chart to analyse performance

Monopar Therapeutics Inc Key Stats

Check Monopar Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$34.81
Open
$34.31
Market Capitalization
$197.6M
Today's Volume
$29.9K
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-3.84
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-59.38%

Stock Returns calculator for Monopar Therapeutics Stock including INR - Dollar returns

The Monopar Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Monopar Therapeutics investment value today

Current value as on today

₹15,24,684

Returns

₹14,24,684

(+1.42K%)

Returns from Monopar Therapeutics Stock

₹14,20,253 (+1.42K%)

Dollar Returns*

₹4,430 (+4.43%)

Indian investors sentiment towards Monopar Therapeutics Stock

7%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Monopar Therapeutics Stock from India on INDmoney has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Monopar Therapeutics Inc

  • Name

    Holdings %

  • HHG PLC

    19.00%

  • Adage Capital Partners Gp LLC

    9.71%

  • RA Capital Management, LLC

    8.29%

  • Point72 Asset Management, L.P.

    1.69%

  • ADAR1 Capital Management LLC

    1.63%

  • Vanguard Group Inc

    1.40%

Analyst Recommendation on Monopar Therapeutics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Monopar Therapeutics(by analysts ranked 0 to 5 stars)

Monopar Therapeutics Share Price Target

What analysts predicted

Upside of 86.42%

Target:

$67.17

Current:

$36.03

Monopar Therapeutics share price target is $67.17, a slight Upside of 86.42% compared to current price of $36.03 as per analysts' prediction.

Monopar Therapeutics Stock Insights

  • Price Movement

    In the last 1 year, MNPR stock has moved up by 1440.3%

Monopar Therapeutics Technicals Summary

Sell

Neutral

Buy

Monopar Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Monopar Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Monopar Therapeutics Inc logo
-19.1%
-0.85%
1368.78%
286.78%
23.22%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.0%
-50.21%
-0.24%
-5.32%
Beone Medicines Ltd logo
-1.83%
10.43%
51.2%
81.32%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.91%
-21.14%
38.29%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
84.06%
58.25%
116.31%
242.42%

About Monopar Therapeutics Inc

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Organization
Monopar Therapeutics
Employees
14
CEO
Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc
Industry
Health Technology

Key Management of Monopar Therapeutics Inc

NameTitle
Dr. Christopher M. Starr Ph.D.
Co-Founder & Independent Executive Chairman of the Board
Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc
Co-Founder, CEO, President & Director
Mr. Andrew J. Cittadine M.B.A.
Chief Operating Officer
Mr. Quan Anh Vu
CFO, Principal accounting officer & Principal financial officer
Dr. Patrice P. Rioux M.D., Ph.D.
Acting Chief Medical Officer

Important FAQs about investing in MNPR Stock from India :

What is Monopar Therapeutics share price today?

Monopar Therapeutics share price today is $36.03 as on at the close of the market. Monopar Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Monopar Therapeutics share?

Monopar Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Monopar Therapeutics stock price today i.e. is closed at $36.03, lower by 33.65% versus the 52 week high.

How to invest in Monopar Therapeutics Stock (MNPR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Monopar Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Monopar Therapeutics Shares that will get you 0.0416 shares as per Monopar Therapeutics share price of $36.03 per share as on August 29, 2025 at 1:26 am IST.

What is the minimum amount required to buy Monopar Therapeutics Stock (MNPR) from India?

Indian investors can start investing in Monopar Therapeutics (MNPR) shares with as little as ₹87.6463 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.46 in Monopar Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Monopar Therapeutics share’s latest price of $36.03 as on August 29, 2025 at 1:26 am IST, you will get 0.2775 shares of Monopar Therapeutics. Learn more about fractional shares .

What are the returns that Monopar Therapeutics has given to Indian investors in the last 5 years?

Monopar Therapeutics stock has given 23.22% share price returns and 18.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?